Literature DB >> 3839188

The response to initial chemotherapy as a prognostic factor in localized Ewing's sarcoma.

O Oberlin, C Patte, F Demeocq, M J Lacombe, M Brunat-Mentigny, M C Demaille, P Tron, B N'Guyen Bui, J Lemerle.   

Abstract

Ninety-five children with localized Ewing's sarcoma were included in a prospective cooperative study. All patients received initial chemotherapy with the purpose of early prevention of metastases and improvement of the conditions of the subsequent local therapy, radiotherapy in all cases, surgical resection in selected cases. Clinical response to initial chemotherapy was evaluated in 67 patients who had measurable soft tissue mass or functional symptoms. This response appeared highly correlated with outcome as the disease-free survival was 57.3% for the 41 good responders and 9% for the 26 bad responders (P less than 0.00001), though 23 of these bad responders reached complete remission with radiotherapy. This study also confirms the prognostic significance for survival of the site of the primary tumor on axial skeleton or on limbs. Nevertheless, this factor had no predictive value for response to chemotherapy, which thus appears to be an independent factor.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3839188     DOI: 10.1016/0277-5379(85)90038-0

Source DB:  PubMed          Journal:  Eur J Cancer Clin Oncol        ISSN: 0277-5379


  9 in total

1.  Curettage, phenolization, and cementation in paediatric Ewing's sarcoma with a complete radiological response to neoadjuvant chemotherapy.

Authors:  Khodamorad Jamshidi; Mehdi Ramezan Shirazi; Abolfazl Bagherifard; Alireza Mirzaei
Journal:  Int Orthop       Date:  2018-08-11       Impact factor: 3.075

2.  High-dose ifosfamide with mesna uroprotection in Ewing's sarcoma.

Authors:  H Jürgens; U Exner; J Kühl; J Ritter; J Treuner; P Weinel; K Winkler; U Göbel
Journal:  Cancer Chemother Pharmacol       Date:  1989       Impact factor: 3.333

3.  Adults with Ewing's sarcoma/primitive neuroectodermal tumor: adverse effect of older age and primary extraosseous disease on outcome.

Authors:  E H Baldini; G D Demetri; C D Fletcher; J Foran; K C Marcus; S Singer
Journal:  Ann Surg       Date:  1999-07       Impact factor: 12.969

Review 4.  Ewing tumour: incidence, prognosis and treatment options.

Authors:  M Paulussen; B Fröhlich; H Jürgens
Journal:  Paediatr Drugs       Date:  2001       Impact factor: 3.022

5.  Initial chemotherapy including ifosfamide in the management of Ewing's sarcoma: preliminary results. A protocol of the French Pediatric Oncology Society (SFOP).

Authors:  F Deméocq; O Oberlin; E Benz-Lemoine; A Boilletot; J C Gentet; J M Zucker; C Behar; P Poutard; D Olive; M Brunat-Mentigny
Journal:  Cancer Chemother Pharmacol       Date:  1989       Impact factor: 3.333

6.  Monitoring the effect of chemotherapy in Ewing's sarcoma of bone with MR imaging.

Authors:  H J van der Woude; J L Bloem; H C Holscher; M A Nooy; A H Taminiau; J Hermans; T H Falke; P C Hogendoorn
Journal:  Skeletal Radiol       Date:  1994-10       Impact factor: 2.199

7.  Histopathological predictive factors in Ewing's sarcoma of bone and clinicopathological correlations. A retrospective study of 261 cases.

Authors:  A Llombart-Bosch; G Contesso; M Henry-Amar; M J Lacombe; O Oberlin; J Dubousset; J Rouëssé; D Sarrazin
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1986

8.  Prognostic factors in localized Ewing's tumours and peripheral neuroectodermal tumours: the third study of the French Society of Paediatric Oncology (EW88 study).

Authors:  O Oberlin; M C Deley; B N Bui; J C Gentet; T Philip; P Terrier; C Carrie; F Mechinaud; C Schmitt; A Babin-Boillettot; J Michon
Journal:  Br J Cancer       Date:  2001-11-30       Impact factor: 7.640

9.  Adult ewing sarcoma: survival and local control outcomes in 102 patients with localized disease.

Authors:  Safia K Ahmed; Steven I Robinson; Scott H Okuno; Peter S Rose; Nadia N Issa Laack
Journal:  Sarcoma       Date:  2013-06-11
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.